Mallinckrodt Pharmaceuticals
MNK
#10255
Rank
โ‚น0.39 B
Marketcap
โ‚น29.58
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Mallinckrodt Pharmaceuticals (MNK)

Earnings in 2023 (TTM): -โ‚น94.45 Billion

According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น1.93 Billion. In 2022 the company made an earning of -โ‚น127.08 Billion a decrease over its 2021 earnings that were of -โ‚น72.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Mallinckrodt Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚น94.45 Billion-25.67%
2022 -โ‚น127.08 Billion76.14%
2021 -โ‚น72.15 Billion-13.63%
2020 -โ‚น83.54 Billion-39.63%
2019 -โ‚น138.37 Billion-61.51%
2018 -โ‚น359.47 Billion-6812.18%
2017 โ‚น5.35 B-185.79%
2016 -โ‚น6.25 Billion-131.27%
2015 โ‚น19.96 B-166.82%
2014 -โ‚น29.88 Billion-319.69%
2013 โ‚น13.59 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น1.516 T-1,616.56%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น18.44 Billion-81.56%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น24.52 Billion-75.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚น738.98 B-839.07%๐Ÿ‡บ๐Ÿ‡ธ USA